Literature DB >> 10882591

Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.

M Stâlhammar-Carlemalm1, T Areschoug, C Larsson, G Lindahl.   

Abstract

The R28 protein of group A streptococcus (GAS) and the Rib protein of group B streptococcus (GBS) are surface molecules that elicit protective immunity to experimental infection. These proteins are members of the same family and cross-react immunologically. In spite of extensive amino acid residue identity, the cross-reactivity between R28 and Rib was found to be limited, as shown by analysis with highly purified proteins and specific antisera. Nevertheless, immunization of mice with purified R28 conferred protection against lethal infection with Rib-expressing GBS strains, and immunization with Rib conferred protection against R28-expressing GAS. Thus, R28 and Rib elicited cross-protective immunity. Characterization of many clinical GAS and GBS isolates expressing R28 or Rib, respectively, indicated that most of them expressed proteins similar to those of the reference strains. Analysis of these data suggests that cross-protection may influence the outcome of natural infections with R28-expressing GAS and Rib-expressing GBS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882591     DOI: 10.1086/315693

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.

Authors:  Shizhen Zhang; Nicole M Green; Izabela Sitkiewicz; Rance B Lefebvre; James M Musser
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

4.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

5.  Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.

Authors:  C Larsson; M Lindroth; P Nordin; M Stålhammar-Carlemalm; G Lindahl; I Krantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

Review 6.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine.

Authors:  Vivek Sagar; René Bergmann; Andreas Nerlich; David J McMillan; D Patric Nitsche Schmitz; Gursharan S Chhatwal
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

8.  The N-terminal domain of the R28 protein promotes emm28 group A Streptococcus adhesion to host cells via direct binding to three integrins.

Authors:  Antonin Weckel; Dorian Ahamada; Samuel Bellais; Céline Méhats; Céline Plainvert; Magalie Longo; Claire Poyart; Agnès Fouet
Journal:  J Biol Chem       Date:  2018-08-27       Impact factor: 5.157

9.  Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

10.  Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Authors:  Hsiao-Hui Yang; Samantha J Mascuch; Lawrence C Madoff; Lawrence C Paoletti
Journal:  Clin Vaccine Immunol       Date:  2008-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.